Last Posted: Oct 04, 2018
- Clinical outcomes in U.S. infants with cystic fibrosis from 2001 to 2012.
Hoch Heather et al. Pediatric pulmonology 2018 Sep - Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis.
Vadagam Pratyusha et al. Journal of managed care & specialty pharmacy 2018 Oct 24(10) 987-997 - Cystic fibrosis in the era of precision medicine.
Paranjape Shruti M et al. Paediatric respiratory reviews 2018 Jan 2564-72 - Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation.
Holtkamp Kim C A et al. Journal of community genetics 2018 Sep - Solving the genome puzzle: With advances in gene technology helping to diagnose very rare diseases, has the new era of personalised medicine finally arrived?
L Geddes, The Guardian, September 21, 2018 - Searching for a diagnosis: how scientists are untangling the mystery of developmental disorders
L Geddes, Mosaic, September 18, 2018 - When should genomic testing be considered for cystic fibrosis?
Wysocki Kenneth et al. Journal of the American Association of Nurse Practitioners 2018 Sep 30(9) 478-479 - Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
Wee Bryan A et al. BMC genomics 2018 Aug (1) 644 - Equitable CF care as a basic human right.
De Boeck Kris et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2016 15(6) 703-704 - Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands.
Dankert-Roelse Jeannette E et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2018 Aug
.png)
No hay comentarios:
Publicar un comentario